ResMed (NYSE: RMD, ASX: RMD) reported Street-beating Q2 results as it boosted production to meet the demand created by Philips’ massive respiratory device recall. The San Diego–based maker of CPAPs and other respiratory devices earned $224.9 million, or $1.53 per share, off nearly $1.034 billion in revenue for the quarter that ended Dec. 31, 2022. […]
MassDevice Article Archive
Glucose monitor maker Know Labs names new CEO, makes other executive changes
Know Labs (NYSE:KNW) announced that it named Ron Erickson as CEO as the company makes a handful of changes at the top. The Seattle-based non-invasive glucose monitor maker’s board unanimously named Erickson, its founder and chair, as CEO. Former CEO Phil Bosua stepped down as an executive officer of the company and board member. Know […]
Nemaura Medical garners U.S.-based purchase order for glucose sensors
Nemaura Medical (Nasdaq:NMRD) announced that it received a purchase order for 5,000 proBEAT glucose sensor subscriptions. HealthFleet, a U.S.-based telehealth provider, made the purchase order. It consists of 75,000 proBEAT glucose sensors over an initial five-month period. Nemaura values the deal at $500,000 in revenue, while HealthFleet possesses the option to increase volumes based on […]
Orthofix launches Mariner deformity pedicle screw system
Orthofix Medical (Nasdaq:OFIX) announced that it initiated the full commercial launch of its Mariner deformity pedicle screw. Lewisville, Texas-based Orthofix also announced the first patient cases with Mariner. It marks the first product launched since the merger between Orthifix and SeaSpine earlier this month. SeaSpine developed the Mariner screw system. In a news release, Orthofix […]
CVRx nearly doubles its revenue in Q4
CVRx (NASDAQ: CVRX) reported Street-beating Q4 results amid increased adoption of its implantable neuromodulation system for treating heart failure symptoms. Minneapolis-based CVRx announced yesterday evening that it lost $10.5 million, or 51¢ per share, off of $7.2 million in revenue for the quarter that ended Dec. 31. 2022. Sales were up 96% compared with the […]
FDA approves Abbott’s spinal cord stimulation system for diabetic peripheral neuropathy
Abbott (NYSE:ABT) announced today that the FDA approved its spinal cord stimulation system for treating painful diabetic peripheral neuropathy (DPN). The Proclaim XR SCS system offers relief to patients with DPN, a debilitating complication of diabetes. These patients need alternatives to traditional treatment approaches like oral medication. Users of Proclaim XR can also use Abbott’s […]
Miach Orthopaedics secures $40M to support its ACL tears implant
Miach Orthopaedics today announced that it’s closed on $40 million in financing to support expanded U.S. commercialization of its Bear implant to treat ACL tears. The financing includes $30 million in Series B equity from lead investors Sectoral Asset Management and Endeavour Vision. Existing investors — including Amzak Health, Smith+Nephew, DSM Venturing and the NFL […]
Integra Lifesciences’ CFO is leaving for the soup business
Integra Lifesciences CFO Carrie Anderson is leaving to take a job at another New Jersey–based company, but it’s not a medtech business. Campbell Soup Co. announced today that Anderson will become its EVP and CFO, effective Feb. 6. She succeeds Mick Beekhuizen, who became president of the Camden, New Jersey–based company’s Meals & Beverages division […]
BCI developer Precision Neuroscience raises $41M Series B
Brain-computer interface (BCI) maker Precision Neuroscience announced today that it closed a $41 million Series B funding round. Bloomberg first reported that the company intended to announce the financing before Precision Neuroscience confirmed it in a LinkedIn post. Forepont Capital Partners led the financing round. According to Bloomberg, it adds to a previous fundraising totaling $12 […]
Embecta opens new global headquarters in New Jersey
Embecta (Nasdaq:EMBC) announced today that it held a grand opening ceremony at its new global headquarters in New Jersey. The BD Diabetes business spinoff opened its new headquarters at 300 Kimball Drive, Suite 300, in Parsippany, New Jersey. The site houses members of the Embecta leadership team, global support functions and North American commercial organization. […]
The year ahead in diabetes care: what to expect in 2023
After a banner year for diabetes technology in 2022, there’s still plenty to look forward to in 2023. Throughout 2022, we saw a wide range of advancements in diabetes technology. We saw launches for next-generation technologies, exciting clinical trial results, rumored spinouts and acquisitions and more. You can read all about the biggest diabetes stories […]
